Could Cannabinoids Fight Cancer? What Lab Studies Were Showing | Research

The takeaway

A Nature Reviews Cancer paper documented that cannabinoids inhibited tumor cell growth in lab and animal models by modulating cell-signaling pathways, while being well tolerated and lacking the toxic effects of conventional chemotherapy.

Read this if you have heard claims about cannabis fighting cancer and want to know what the science actually showed.

Cannabinoids inhibited tumor growth in lab and animal models without conventional chemo toxicity

What the researchers found

Beyond their established palliative effects in cancer patients (preventing nausea, vomiting, pain, and stimulating appetite), cannabinoids had been shown to inhibit tumor cell growth in cell cultures and animal models. These anti-tumor effects occurred through modulation of key cell-signaling pathways. Importantly, cannabinoids were generally well tolerated and did not produce the generalized toxic effects seen with conventional chemotherapies.

The review posed the question of whether cannabinoids could be developed into new anticancer therapies, marking one of the first times this question was seriously raised in a top-tier cancer research journal.

Why it matters

Publication in Nature Reviews Cancer gave significant visibility and credibility to cannabinoid anticancer research. The observation that cannabinoids could inhibit tumor growth while being well tolerated contrasted sharply with the toxicity of conventional chemotherapy and stimulated further investigation.

The numbers in context

No specific quantitative data were provided in the abstract.

How the study worked

This was a review article published in Nature Reviews Cancer evaluating the evidence for anticancer properties of cannabinoids from cell culture and animal model studies.

What this study cannot tell us

The evidence was entirely preclinical (cell cultures and animal models). Tumor inhibition in the lab does not necessarily predict clinical anticancer efficacy. The mechanisms by which cannabinoids affected tumor growth were not fully elucidated.

How to read the evidence

This is a review in a prestigious cancer journal synthesizing preclinical evidence, providing moderate-level evidence from lab and animal studies.

When this study was published

Published in 2003. Despite continued research, no cannabinoid has been approved as an anticancer treatment as of the 2020s.

The bigger picture

Since this 2003 review, cannabinoid anticancer research has expanded considerably, with studies investigating effects on various cancer types. However, clinical trials in humans remain limited, and no cannabinoid has been approved as an anticancer treatment. The gap between promising preclinical results and clinical translation remains a major challenge in this field.

Questions still open

Have cannabinoid anticancer effects translated to human clinical trials? Which cancer types appear most responsive to cannabinoid treatment? Could cannabinoids be used alongside conventional chemotherapy?

Common questions

Can cannabis cure cancer?

This review documented that cannabinoids inhibited tumor growth in lab dishes and animal models, but this does not mean cannabis cures cancer in humans. Clinical trials in cancer patients remain very limited, and no cannabinoid has been approved as an anticancer treatment.

How might cannabinoids fight cancer?

The review described cannabinoids modulating key cell-signaling pathways that control tumor cell growth. This is different from how conventional chemotherapy works and appeared to produce fewer toxic side effects in preclinical models.

Read the original research

Cannabinoids: potential anticancer agents.

Nature reviews. Cancer, 3(10), 745-55

View on PubMed ↗

Citation

Guzmán, Manuel. (2003). Cannabinoids: potential anticancer agents.. Nature reviews. Cancer, 3(10), 745-55.